As a newly formed joint venture located in China, Medicilon/MPI Preclinical Research Shanghai provides a portfolio of preclinical discovery and development services to pharmaceutical and biotechnology companies. The new company has brought the best of its parent companies, Shanghai Medicilon and MPI Research, to assure top quality, on-time GLP and non-GLP studies. With its global team of talented scientific professionals, the latest technology, and a problem-solving culture, Medicilon/MPI Preclinical Research Shanghai welcomes your toughest preclinical research challenges.